Back
ESC2025 Premium Access

Empagliflozin significantly reduces circulating markers of endothelial dysfunction in Ischemia with Non-Obstructive Coronary Arteries (INOCA) and coronary microvascular dysfunction: a pilot trial

Session: Cardiovascular disease in women around the world
Topic: Cardiovascular Disease in Women
Speaker: Doctor O. Quesada (Cincinnati, US)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Odayme Quesada

The Christ Hospital Health Network, Cincinnati (United States of America)
0 follower

7 more presentations in this session

Sex differences in health status trajectories among Chinese patients with angina pectoris: insights from the GREAT registry study

Speaker: Professor X. Du (Beijing, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Sex disparities in ischaemic heart disease mortality in South Asia: a global burden of disease 2021 analysis

Speaker: Ms T. Rahaman (Bologna, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of atorvastatin on serum oestradiol and estrone concentrations in postmenopausal women with chronic coronary artery disease: a randomized trial.

Speaker: Miss N. Faria (Sao Paulo, BR)

Access
Abstract
Slides
Video
Like
Thumbnail

Coronary artery disease-related sudden cardiac arrest in women

Speaker: Doctor O. Weizman (Paris, FR)

Access
Abstract
Slides
Video
Like
Thumbnail

Bridging the gender gap in TAVI: real-world evidence from a single-centre study

Speaker: Doctor R. Batista Louro (Evora, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Cardiovascular disease in women around the world

Speakers: Doctor O. Quesada, Professor X. Du, Ms T. Rahaman, Miss N. Faria, Doctor O. Weizman...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources